Anonymous wrote:Just FYI BCBS has gotten so expensive that IMO it is not worth the cost anymore. Switched to Aetna, have been very happy and never looked back. Foreign Service Benefit Plan to be specific
Anonymous wrote:I don't understand how the plan brochure and formulary get away with not stating what the plan allowance is? What is the point of telling me I'll pay x% of an unknown number?
Anonymous wrote:Anonymous wrote:Does anyone know of any plan that can be purchased on the DC Exchange that would cover Wegovy?
Lol.
No.
Anonymous wrote:Anonymous wrote:I don't understand how the plan brochure and formulary get away with not stating what the plan allowance is? What is the point of telling me I'll pay x% of an unknown number?
These numbers are negotiated. Either they have not arrived at an agreed upon price with Norvo yet, or they have but it isn’t public yet.
Anonymous wrote:Anonymous wrote:Anonymous wrote:Anonymous wrote:This is not good for me. I have BCBS Blue Focus. I may end up changing to something else (I'll be in the new postal service plans).
Wegovy isn’t on the 2025 formulary for blue focus
I saw that after I looked-yikes.
Looking at other plans now and also considering getting the med from another source. Maybe one of those places that charge by the month.
This is not a real solution. The compounding pharmacies are only allowed to sell compounded Semaglutide right now because there is a shortage of Wegovy. Once the shortage is over, which it should be very very soon, they won’t be able to violate the patent by selling it. so this is not a long-term solution.
Also, my doctor won’t allow it because of safety concerns. But nobody seems to care about safety concerns. So.
Anonymous wrote:I don't understand how the plan brochure and formulary get away with not stating what the plan allowance is? What is the point of telling me I'll pay x% of an unknown number?
Anonymous wrote:Anonymous wrote:Anonymous wrote:This is not good for me. I have BCBS Blue Focus. I may end up changing to something else (I'll be in the new postal service plans).
Wegovy isn’t on the 2025 formulary for blue focus
I saw that after I looked-yikes.
Looking at other plans now and also considering getting the med from another source. Maybe one of those places that charge by the month.
Anonymous wrote:Anonymous wrote:This is not good for me. I have BCBS Blue Focus. I may end up changing to something else (I'll be in the new postal service plans).
Wegovy isn’t on the 2025 formulary for blue focus
Anonymous wrote:I don't understand how the plan brochure and formulary get away with not stating what the plan allowance is? What is the point of telling me I'll pay x% of an unknown number?
Anonymous wrote:I was doing a tad bit of research this AM. It sorta seems like GEHA and United Health care has some coverage for Wegovy and Zepbound. I need to do some investigating further.
I saw this spreadsheet on Reddit. I don't know if it's 100% accurate. Plus it seems to be missing some plans. https://docs.google.com/spreadsheets/u/1/d/1cwgtYouOl_aAXRe_Nq9gH0CX8cuyW3FfsXgAjtDYoCg/htmlview?pli=1#
Someone said that on 10/19 there will be some more pricing releasing done and BCBS reviews meds quarterly. I think they just did a review but I'm not sure.
Anonymous wrote:Anonymous wrote:Anonymous wrote:Anonymous wrote:Anonymous wrote:Will this switch affect FEP Standard as well?
Yes, moving to Tier 3 on both.
So it moves from the insured paying 30% to the insured paying 50%? I currently pay $24.99/month, so it won’t be that much more. Or am I missing something?
Yes -- you are missing something. As I posted above, the coupon is what is getting your payment down to $24.99 and the coupon is limited to $225 of savings. So if the amount you have to pay per 50% coinsurance is more than $225 a fill, you will pay it. And I can almost guarantee it will be far more than that. I'm estimating 2025 cost to be somewhere between $400 and $600 a month on BCBS Standard FEP with the coupon -- but costs fluctuate and who knows what kind of negotiating has taken place with Norvo regarding 2025 price.
Out of pocket pharmaceutical costs appear to be capped at $2000 in 2025. That’s $167 per month. Seems reasonable.